Log on / register
Feedback | Support | My details
Open AccessHighly AccessResearch article

Sensitivity and specificity of the Major Depression Inventory in outpatients

Pim Cuijpers1 email, Jack Dekker1,2 email, Annemieke Noteboom2 email, Niels Smits1 email and Jaap Peen1,2 email

Department of Clinical Psychology, VU University Amsterdam, Amsterdam, The Netherlands

Mentrum Mental Health Care, Amsterdam, The Netherlands

author email corresponding author email

BMC Psychiatry 2007, 7:39doi:10.1186/1471-244X-7-39

Published: 9 August 2007

Abstract

Background

The Major Depression Inventory (MDI) is a new, brief, self-report measure for depression based on the DSM-system, which allows clinicians to assess the presence of a depressive disorder according to the DSM-IV, but also to assess the severity of the depressive symptoms.

Methods

We examined the sensitivity, specificity, and psychometric qualities of the MDI in a consecutive sample of 258 psychiatric outpatients. Of these patients, 120 had a mood disorder (70 major depression, 49 dysthymia). A total of 139 subjects had a comorbid axis-I diagnosis, and 91 subjects had a comorbid personality disorder.

Results

Crohnbach's alpha of the MDI was a satisfactory 0.89, and the correlation between the MDI and the depression subscale of the SCL-90 was 0.79 (p < .001). Subjects with major depressive disorder (MDD) had a significantly higher MDI score than subjects with anxiety disorders (but no MDD), dysthymias, bipolar, psychotic, other neurotic disorders, and subjects with relational problems. In ROC analysis we found that the area under the curve was 0.68 for the MDI. A good cut-off point for the MDI seems to be 26, with a sensitivity of 0.66, and a specificity of 0.63. The indication of the presence of MDD based on the MDI had a moderate agreement with the diagnosis made by a psychiatrist (kappa: 0.26).

Conclusion

The MDI is an attractive, brief depression inventory, which seems to be a reliable tool for assessing depression in psychiatric outpatients.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.